Influenza virus vaccination of patients with systemic lupus erythematosus: Effects on disease activity

Journal of Rheumatology

Volumn 27, Issue 7, 2000, Pages 1681-1685

  Abu Shakra, Mahmoud ^a   Zalmanson, Svetlana ^b   Neumann, Lily ^b   Flusser, Daniel ^b   Sukenik, Shaul ^b   Buskila, Dan ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b NONE

Author keywords

Autoimmunity; Influenza virus; SLE; SLEDAI; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG SAFETY; FEMALE; HUMAN; INFLUENZA VACCINATION; KIDNEY DISEASE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; HUMANS; INFLUENZA VACCINES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0033940408     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cooper GS, Dooley MA, Treadwell EL, St. Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 1998;41:1714-24.
2. Strom BL, Reidenberg MM, West S, Snyder ES, Freundlich B, Stolley PD. Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol 1994;140:632-42.
3. Gilkeson GS, Pippen AMM, Pisetsky DS. Induction of cross-reactive anti-DNA antibodies in pre-autoimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest 1995; 95;1398-402.
4. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 1995;22:1259-64.
5. Urowitz MB, Gladman DD, Abu-Shakra M, Farewell V. Mortality studies in SLE. III. Improved survival over 24 years. J Rheumatol 1997;24:1061-5.
6. Battafarano DF, Battafarano NJ, Larsen L, et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 1998;10:1828-34.
7. Louie JS, Nies KM, Shoji KT, et al. Clinical and antibody responses after influenza immunization in SLE. Ann Intern Med 1978; 88:790-2.
8. Williams GW, Steinberg AD, Reinertsen L, Klassen LW, Decker JL, Dolin R. Influenza immunization in SLE. A double blind trial. Ann Intern Med 1978;88:729-34.
9. Brodman R, Gilfillan R, Glass D, Schur P. Influenzal vaccine response in SLE. Ann Intern Med 1978;88:735-40.
10. Ristow SC, Douglas RG, Condemi JJ. Influenza vaccination of patients with SLE. Ann Intern Med 1978;88:786-9.
11. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
12. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
13. Petri M, Genovese M, Engle E, Hochberg M. Definition, incidence and clinical description of flare in SLE: a prospective cohort study. Arthritis Rheum 1991;34:937-44.
14. Stata Corp. Stata Statistical Software: Release 5.0. College Station, Texas: Stata Corp.; 1997.
15. Cohen AD, Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmun 1996;9:699-703.
16. Meyboom RHB, Fucik H, Edwards IR. Thrombocytopenia reported in association with hepatitis B and A vaccines [letter]. Lancet 1995;345:1638.
17. Tudela P, Marti S, Bonal J. SLE and vaccination against hepatitis B. Nephron 1992;62:236-7.
18. Biron P, Montpetit P, Infante-Rivard C, Lery L. Myasthenia gravis after general anesthesia and hepatitis B vaccine. Arch Intern Med 1988;148:2685.
19. Hurwitz ES, Schonberger LB, Nelson DB, Holman RC. Guillain-Barre syndrome and the 1978-1979 influenza vaccine. N Engl J Med 1981;304:1557-61.
20. Uhari M, Rantala H, Niemela M. Cluster of childhood Guillain-Barre cases after an oral poliovaccine campaign. Lancet 1989; 2:440-1.
21. Ayvazian LF, Badger TL. Disseminated lupus erythematosus occurring among student nurses. N Engl J Med 1948;239:565-70.
22. Hess EV, Hahn HB. Influenza immunization in lupus erythematosus: Safe, effective? Ann Intern Med 1978;88:833-4.
23. Immunization Practices Advisory Committee. General recommendations on immunization: guidelines from the Immunization Practices Advisory Committee, Centers for Disease Control. Ann Intern Med 1989;111:133-42.
24. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single centre. II. Predictor variables for mortality. J Rheumatol 1995;22:1265-70.
25. Fortin PR, Abrahamowicz M, Danoff D. Small changes in outpatient lupus activity are better detected by clinical instruments than by laboratory tests. J Rheumatol 1995;22:2078-83.
26. Abrahamowicz M, Fortin PR, du Berger R, Nayak V, Neville C, Liang MH. The relationship between disease activity and expert physician's decision to start major treatment in active SLE: a decision aid for development of entry criteria for clinical trials. J Rheumatol 1998;25:277-84.